Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC015389 | Panoply™ Human SULF2 Knockdown Stable Cell Line | Inquiry |
| CSC-SC015389 | Panoply™ Human SULF2 Over-expressing Stable Cell Line | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD15748Z | Human SULF2 adenoviral particles | Inquiry |
| LV26982L | human SULF2 (NM_198596) lentivirus particles | Inquiry |
| LV26983L | human SULF2 (NM_018837) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH420684 | shRNA set against Human SULF2 (NM_018837.3) | Inquiry |
| SHH420688 | shRNA set against Mouse SULF2 (NM_028072.5) | Inquiry |
| SHH420692 | shRNA set against Rat SULF2 (NM_001034927.1) | Inquiry |
| SHL047250 | shRNA set against Rat Sulf2(NM_001034927.1) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| MiUTR3H-10967 | SULF2 miRNA 3'UTR clone | Inquiry |
| MiUTR3H-10965 | SULF2 miRNA 3'UTR clone | Inquiry |
| MiUTR1R-07792 | SULF2 miRNA 3'UTR clone | Inquiry |
| CDFR004413 | Rat Sulf2 cDNA Clone(NM_001034927.1) | Inquiry |
| CDFH018949 | Human SULF2 cDNA Clone(NM_001161841.1) | Inquiry |
| CDFG012899 | Human SULF2 cDNA Clone(NM_198596.2) | Inquiry |
| CDCR354178 | Human SULF2 ORF Clone(NM_001161841.1) | Inquiry |
| CDCR371442 | Rat Sulf2 ORF Clone(NM_001034927.1) | Inquiry |
| MiUTR3H-10966 | SULF2 miRNA 3'UTR clone | Inquiry |
| CDCS408705 | Human SULF2 ORF Clone (BC020962) | Inquiry |
| CDCH402807 | Mouse SULF2 ORF clone(NM_028072.5) | Inquiry |
| CDCH402806 | Mouse SULF2 ORF clone(NM_001252579.1) | Inquiry |
| CDCH402805 | Mouse SULF2 ORF clone(NM_001252578.1) | Inquiry |
| CDCH087470 | human SULF2 ORF clone (NM_198596.2) | Inquiry |
| CDCB183724 | Rabbit SULF2 ORF clone (XM_008274805.1) | Inquiry |
| CDCS408706 | Human SULF2 ORF Clone (BC110539) | Inquiry |
| CDCB159834 | Human SULF2 ORF clone (BC020962) | Inquiry |